+499.5%
MRNA vs EOSE
-49.1%
+548.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EOSE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +10.9% | -13.1% | -4.5% |
| 7D | +5.5% | +19.0% | -13.5% | +0.9% |
| 30D | +158.7% | +1.6% | +157.2% | +157.8% |
| 3M | +182.1% | -52.0% | +234.1% | +213.0% |
| 6M | +151.8% | -42.5% | +194.3% | +166.7% |
| YTD | +393.6% | -66.1% | +459.7% | +457.3% |
| 1Y | +499.5% | -47.1% | +546.6% | +585.4% |
| All | +499.5% | -49.1% | +548.5% | +585.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EOSE.
Daily Out/Under-Performance
Portfolio return minus EOSE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EOSE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EOSE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling